Johnson & Johnson is in talks with India s government to begin a clinical trial of its single-dose COVID-19 vaccine in the country, the company said on Friday. The U.S. drugs and healthcare giant s vaccine is currently approved for use in the United States, the European Union and other nations including Thailand and South Africa. The news comes as some parts of India face a shortage of vaccine supplies just as the country of 1.3 billion battles a second wave of COVID-19 infections. India s government, however, has said there is no shortage of shots. The Indian Express newspaper reported earlier on Friday that J&J had sent a letter to India s Central Drugs Standard Control Organisation (CDSCO) saying it would very shortly apply for permission to conduct clinical bridging trials in India .
Message :
Required fields
BENGALURU, April 9 (Reuters) - Johnson & Johnson is
in talks with India s government to begin a clinical trial of
its single-dose COVID-19 vaccine in the country, the company
said on Friday.
The U.S. drugs and healthcare giant s vaccine is currently
approved for use in the United States, the European Union and
other nations including Thailand and South Africa.
The news comes as some parts of India face a shortage of
vaccine supplies just as the country of 1.3 billion battles a
second wave of COVID-19 infections. India s government, however,
has said there is no shortage of shots.
The Indian Express newspaper reported earlier on Friday that
Johnson & Johnson (NYSE:JNJ), Pfizer, Inc (NYSE:PFE) - J&J Seeks To Conduct Study For COVID-19 Vaccine In India: Reuters benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
BENGALURU: Johnson & Johnson is in talks with India s government to begin a clinical trial of its single-dose COVID-19 vaccine in the country, the company said on Friday.
The US drugs and healthcare giant s vaccine is currently approved for use in the United States, the European Union and other nations including Thailand and South Africa.
The news comes as some parts of India face a shortage of vaccine supplies just as the country of 1.3 billion battles a second wave of Covd-19 infections. India s government, however, has said there is no shortage of shots.
A report said that J&J had sent a letter to India s Central Drugs Standard Control Organisation (CDSCO) saying it would very shortly apply for permission to conduct clinical bridging trials in India .
Johnson & Johnson, Indian government in talks for single-dose COVID-19 vaccine trial, company says channelnewsasia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from channelnewsasia.com Daily Mail and Mail on Sunday newspapers.